This site is intended for health professionals only
Newsletter
Hospital Healthcare Europe
Login
Twitter
Linkedin
Facebook
Select Language
English
French
German
Italian
Spanish
News
Views
Reviews & Research
Clinical
Cardiovascular
Dermatology
Gastroenterology
Medicines safety
Mental health
Neurology
Oncology
Paediatrics
Respiratory
Rheumatology
Sponsored
Clinical Excellence
Cardiology
Respiratory
Events
News
Views
Reviews & Research
Clinical
Cardiovascular
Dermatology
Gastroenterology
Medicines safety
Mental health
Neurology
Oncology
Paediatrics
Respiratory
Rheumatology
Sponsored
Clinical Excellence
Cardiology
Respiratory
Events
Home
>
Drug development
Drug development
First treatment for rare genetic condition
Novartis extends leadership in clinical trial data transparency
Understanding the sporicidal action of VPHP
Avillion Group Partners and Pfizer to co-develop BOSULIF®
Takeda to market the CALCICHEW® portfolio in the UK and Ireland
Sanofi and Fraunhofer-Gesellschaft announce creation of natural product centre of excellence
Issues in the interchangeability of generic drugs: part III
FedEx temperature controlled packaging portfolio
Support for the future of UK bioscience sector
Orion and Mylan settle patent dispute over Stalevo®
NICE recommends Revolade®
Two-year data from clinical trial of HUMIRA®
« Previous
1
…
3
4
5
6
7
…
29
Next »
Most read
1
Transcranial magnetic stimulation brain connectivity changes in major depression visible on MRI scan
by Rod Tucker
2
Oral vitamin A could become an alternative to isotretinoin for acne
by Rod Tucker
3
Amino acids supplement reduces muscle wasting and improves gut function in critically ill
by Rod Tucker
4
Less than two-thirds of patients alive 10 years after out-of-hospital cardiac arrest
by Rod Tucker
5
Launch of the new Hospital Pharmacy Europe Mobile App
by aporter2
Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Subscribe
x
Search for: